Theme: Transforming Health through Vaccine Innovations

Euro Vaccines 2016

Renowned Speakers

Euro Vaccines 2016

Conferenceseries LLC invites all the participants across the globe to attend “10th Euro Global Summit and Expo on Vaccines & Vaccination” which will be held during June 16–18, 2016 in Rome, Italy which includes Prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions. The Theme of the conference is "Transforming Health through Vaccine Innovations".

Euro Vaccines 2016 hosting presentations from Global Leaders in the field across the Globe and bringing together vaccine stakeholders including academic researchers, public health clinicians, vaccine policy makers, corporate and vaccine manufacturers. There will be opportunities for those selected to present at the meeting to also publish a manuscripts and abstracts from their talk in the Journal of Vaccines and Vaccination or its sister publication Immunome Research.

 Track 1: Vaccines against Infectious diseases:

A vaccine is an inactivated form of bacteria or virus that is injected into the body to simulate an actual infection. Because the injected microorganisms are 'dead,' they don't cause a person to become sick. Instead, vaccines stimulate an immune response by the body that will fight off that type of illness. It covers infectious disease targets and non-infectious disease targets. To generate vaccine-mediated protection is a complex challenge. Currently available vaccines have largely been developed empirically, with little or no understanding on how they activate the immune system. Their early protective efficacy is primarily conferred by the induction of antigen-specific antibodies. However, there is more to antibody-mediated protection than the peak of vaccine-induced antibody titers.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; National Adult & Influenza Immunization Summit NAIIS, May 10–12, 2016; 10th ISV Annual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; World Vaccines Congress, 10-12 April, Washington D.C., USA; 6th Immunotherapeutics Immunomonitoring Conference California, USA; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA

Track 2: Cancer Vaccines:

Immunotherapeutics is treatment that uses your body's own immune system to help fight cancer. Get information about the different types of immunotherapy and the types of cancer they are used to treat. The main types of immunotherapy now being used to treat cancer include:

  1. Cancer vaccines
  2. Monoclonal antibodies
  3. Immune checkpoint inhibitors
  4. Other, non-specific immunotherapies

Some types of immunotherapy are also sometimes called biologic therapy or biotherapy.

In the last few decades immunotherapy has become an important part of treating some types of cancer. Newer types of immune treatments are now being studied, and they’ll impact how we treat cancer in the future.

Immunotherapy includes treatments that work in different ways. Some boost the body’s immune system in a very general way. Others help train the immune system to attack cancer cells specifically. Immunotherapy works better for some types of cancer than for others. It’s used by itself for some of these cancers, but for others it seems to work better when used with other types of treatment.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; International Conference on Cancer Immunology and Immunotherapy, July 28-30, 2016, Australia; 12th Euro Global Summit on Cancer Therapy, Sept 26-28, 2016, UK; International Conference and Exhibition on Pediatric Oncology, Aug 4-6, 2016, Canada; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; 6th Immunotherapeutics Immunomonitoring Conference California, USA; National Adult & Influenza Immunization Summit NAIIS, May 10–12, 2016; 10th ISV Annual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; World Vaccines Congress, 10-12 April, Washington D.C., USA; 6th Immunotherapeutics Immunomonitoring Conference California, USA; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA

Track 3: Vaccine Products and Delivery Technologies:

Drug delivery systems are engineered technologies for the targeted delivery and/or controlled release of therapeutic agents. Drugs have long been used to improve health and extend lives. The practice of drug delivery has changed dramatically in the last few decades and even greater changes are anticipated in the near future. Biomedical engineers have not only contributed substantially to our understanding of the physiological barriers to efficient drug delivery—such as transport in the circulatory system and drug movement through cells and tissues—they have contributed to the development of a number of new modes of drug delivery that have entered clinical practice.  Role of vaccine delivery technologies includes rational development of vaccines, achieving immunization goals, supporting best clinical practice.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, March 7-9, 2016, Spain; 9th World Drug Delivery Summit, June 30-July 2, 2016, USA; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 13th Global Vaccines & Vaccination Summit and Expo, November 08-09, 2016 Istanbul, Turkey; Drug Delivery Congress Europe, Germany; 13th Annual International Nanomedicine and Drug Delivery Symposium, USA; Vaccines for Children & Vaccine Preventable Disease Conference South Iselin, NJ; National Adult & Influenza Immunization Summit NAIIS, May 10–12, 2016; 10th ISV Annual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; World Vaccines Congress, 10-12 April, Washington D.C., USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA

Track 4: Vaccine Research & Development:

Vaccine Development is an activity that focuses on a variety of technological initiatives and applied research, which enhance and promote improved systems and practices for vaccine safety. In the past year, the unprecedented Ebola disease outbreak galvanized research and industry response and as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges. Vaccines development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. The current system for developing, testing, and regulating vaccines developed during the 20th century as the groups involved standardized their procedures and regulations.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA

Track 5: Viral Vaccines:

Most vaccines against viral infection are effective at preventing disease. However, they are not 100% effective for a number of reasons, reactions can occur after vaccinations.

It is difficult for many of us today to appreciate the dangers of childhood viral infections.

Most of the vaccines in use against viruses are very effective at preventing disease. However, for a variety of reasons, they can fail:

  • The vaccine becomes inactive due to incorrect storage, if used past its expiry date, or if incorrectly administered.
  • Individuals unpredictably fail to produce an adequate immune response to the vaccine.
  • Vaccine immunity “fades” over time.

 The different vaccine combinations at each time point do not interfere with one another and there is no increased risk of serious side-effects when they are given at the same time.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Vaccine Summit, UK; BIT's 6th Annual World Congress of Vaccine, China; 9th Vaccines & ISV Congress, South Korea; World Vaccines Congress, USA; 6th Immunotherapeutics Immunomonitoring Conference California, USA; 2nd Antivirals Congress Massachusetts, United States; Vaccinology conference Sydney Australia; Vaccines R&D conference-2015 A New Era in Vaccine Discovery Baltimore, USA; Moldova Vaccine Summit, UK; Immunotherapy and Vaccine Summit Boston, USA

Track 6: Bacterial Vaccines:

Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Antibodies are built against that particular bacteria, and prevents bacterial infection later.

Most vaccines against bacterial infections are effective at preventing disease, reactions can occur after vaccinations. Vaccines are available against tuberculosis, diphtheria, tetanus, pertussis, Haemophilus influenzae type B, cholera, typhoid, and Streptococcus pneumoniae.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA

Track 7: Vaccines for Respiratory Infections:

Population protection by vaccination against infections has been one of the major achievements of public health and is of considerable importance in controlling respiratory disease. Our mandate is to prevent, reduce or eliminate vaccine-preventable and infectious respiratory diseases; reduce the negative impact of emerging and re-emerging respiratory infections. Viral respiratory infections continue to cause significant morbidity and mortality in infants and young children as well as in at-risk adults and the elderly. Although many viral pathogens are capable of causing acute respiratory disease, vaccine development has to focus on a limited number of pathogens (i.e., agents that commonly cause serious lower respiratory disease). Inactivated and, more recently, live attenuated influenza virus vaccines are the mainstay of interpandemic influenza prevention, but vaccines are not available yet for other important viruses such as respiratory syncytial virus, metapneumovirus, the parainfluenza viruses, and avian influenza virus with pandemic potential. Reverse genetics systems that allow rational vaccine development are now widely used, and considerable progress has been made in preclinical and clinical development of novel respiratory virus vaccines.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA

Track 8: HPV Vaccines:

Human Papillomavirus (HPV) vaccine is an inactivated (not live) vaccine which protects against four major types of HPV.

These include two types that cause about 70% of cervical cancer and two types that cause about 90% of genital warts. HPV vaccine can prevent most genital warts and most cases of cervical cancer. Protection from HPV vaccine is expected to be long-lasting. But vaccinated women still need cervical cancer screening because the vaccine does not protect against all HPV types that cause cervical cancer.

Routine HPV Vaccination                                           

  • HPV vaccine is routinely recommended for girls 11 and 12 years of age
  • The HPV4 vaccine (the type recommended for prevention of genital warts in girls) may also be given in three doses to boys aged 9 to 26.

It is important for girls to get HPV vaccine before their first sexual contact -- because they have not been exposed to HPV.  For these girls, the vaccine can prevent almost 100% of disease caused by the four types of HPV targeted by the vaccine. However, if a girl or woman is already infected with a type of HPV, the vaccine will not prevent disease from that type. The vaccine is also recommended for girls and women 13 through 26 years of age who did not receive it when they were younger.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; International Conference on Human Papillomavirus, May 2-3, 2016, USA; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 13th Global Vaccines & Vaccination Summit and Expo, November 08-09, 2016 Istanbul, Turkey; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA; Annual Pennsylvania Immunization Conference, June 16, 2016, PA, USA

Track 9: Childhood Vaccines:

Vaccination given to children is called children Immunization. It is currently recommended that all children receive vaccination against the infectious diseases unless the child has special circumstances, such as a compromised immune system or neurological disorders. In our mobile society, over a million people each day people travel to and from other countries, where many vaccine-preventable diseases remain relatively common. Without vaccines, epidemics of many preventable diseases could return, resulting in increased - and unnecessary - illness, disability, and death among children.

We have record or near record low levels of vaccine-preventable childhood diseases in the United States, but that does not mean these have disappeared. Many of the viruses and bacteria are still circulating in this country or are only a plane ride away. That’s why it’s important that children, especially infants and young children receive recommended immunizations on time.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, Chicago, USA; 13th Global Vaccines & Vaccination Summit and Expo, November 08-09, 2016 Istanbul, Turkey; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA; Annual Pennsylvania Immunization Conference, June 16, 2016, PA, USA


Track 10: HIV Vaccines:

An AIDS vaccine does not yet exist, but efforts to develop a vaccine against HIV, the virus that causes AIDS, have been underway for many years. An HIV vaccine could be effective in either of two ways. A “preventive” vaccine would stop HIV infection occurring altogether, whereas a “therapeutic” vaccine would not stop infection, but would prevent or delay illness in people who do become infected, and might also reduce the risk of them transmitting the virus to other people. Although a preventive vaccine would be ideal, therapeutic vaccines would also be highly beneficial. The basic idea behind all HIV vaccines is to encourage the human immune system to fight HIV.

 

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Annual Conference on Virulent HIV Vaccines, July 28-30, 2016 Thailand; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, Chicago, USA; 13th Global Vaccines & Vaccination Summit and Expo, November 08-09, 2016 Istanbul, Turkey; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; HIV Research for Prevention 2016, 17-21 October, Chicago, USA; International AIDS Conference 2016, July 17-19, 2016, Durban, South Africa; HIV Trials Network Meeting, MAY 18-20, 2016, Washington D.C., USA; HIV Vaccines (X8), March 20—24, 2016, California, USA; HIV Research for Prevention 2016 (HIVR4P), October 17- 20, 2016, Chicago, USA

Track 11: Hepatitis Vaccines:

Hepatitis is an inflammation of the liver. The condition can be self-limiting or can progress to fibrosis (scarring), cirrhosis or liver cancer. Hepatitis viruses are the most common cause of hepatitis in the world but other infections, toxic substances (e.g. alcohol, certain drugs), and autoimmune diseases can also cause hepatitis.

There are 5 main hepatitis viruses, referred to as types A, B, C, D and E. These 5 types are of greatest concern because of the burden of illness and death they cause and the potential for outbreaks and epidemic spread. In particular, types B and C lead to chronic disease in hundreds of millions of people and, together, are the most common cause of liver cirrhosis and cancer.

Hepatitis A and E are typically caused by ingestion of contaminated food or water. Hepatitis B, C and D usually occur as a result of parenteral contact with infected body fluids. Common modes of transmission for these viruses include receipt of contaminated blood or blood products, invasive medical procedures using contaminated equipment and for hepatitis B transmission from mother to baby at birth, from family member to child, and also by sexual contact.

Acute infection may occur with limited or no symptoms, or may include symptoms such as jaundice (yellowing of the skin and eyes), dark urine, extreme fatigue, nausea, vomiting and abdominal pain.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; International Conference on Hepatitis Vaccines, July 25-26, 2016, Australia; 3rd World Congress on Hepatitis and Liver Diseases, Oct 17-19, 2016, UAE; 2nd International Conference on Hepatology, May 12-14, 2016, USA; 4th International Conference on HIV/AIDS, STDs, & STIs, Oct 3-5, 2016, USA; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA; Annual Pennsylvania Immunization Conference, June 16, 2016, PA, USA

Track 12: Splenectomy Vaccines:

The splenectomized patient should be vaccinated to decrease the risk of overwhelming postsplenectomy sepsis (OPSS) due to organisms such as Streptococcus pneumonia, Haemophilus influenzae type B, and Neisseria meningitidis.

To reduce the incidence of fulminant infections in this risk group, guides and recommendations for systematic preventive measures have been designed, based on vaccination, antibiotic prophylaxis and health education.

The vaccines currently recommended in splenectomized adults in our setting are the 23-valent pneumococcal polysaccharide (PN23), the conjugated meningococcal C (MCC) and the Haemophilus influenzae type b (Hib) vaccines. If the surgery is elective, vaccination should be carried out at least 2 weeks before the intervention to achieve an optimal humoral response. If this is not possible, in order not to lose any opportunity for vaccination, the patient should be vaccinated as soon as practically possible after the operation and, in all cases, before hospital discharge.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, Chicago, USA; 13th Global Vaccines & Vaccination Summit and Expo, November 08-09, 2016 Istanbul, Turkey; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA; Annual Pennsylvania Immunization Conference, June 16, 2016, PA, USA

Track 13: Toxoid Vaccines:

When the immune system receives a vaccine containing a harmless toxoid, it learns how to fight off the natural toxin. The immune system produces antibodies that lock onto and block the toxin. Vaccines against diphtheria and tetanus are examples of toxoid vaccines. Toxoids are used as vaccines because they induce an immune response to the original toxin or increase the response to another antigen since the toxoid markers and toxin markers are preserved. For bacteria that secrete toxins, or harmful chemicals, a toxoid vaccines might be the answer. These vaccines are used when a bacterial toxin is the main cause of illness. Scientists have found that they can inactivate toxins by treating them with formalin, a solution of formaldehyde and sterilized water. Such “detoxified” toxins, called toxoids and are safe for use in vaccines.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, Chicago, USA; 13th Global Vaccines & Vaccination Summit and Expo, November 08-09, 2016 Istanbul, Turkey; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA; Annual Pennsylvania Immunization Conference, June 16, 2016, PA, USA

Track 14: Pentavalent Vaccine:

A pentavalent vaccine is five individual vaccines conjugated in one intended to actively protect infant children from 5 potentially deadly diseases: Haemophilus Influenza type B (the bacteria that causes meningitis, pneumonia and otitis), Whooping Cough (or Pertussis), Tetanus, Hepatitis B and Diphtheria.

Pentavalent vaccine comes in single-dose glass bottles called vials, which should be stored at between +2°C and +8°C. It should never be frozen, or allowed to become warmer than +8°C, as this will destroy its effectiveness. If it is allowed to stand for a long time, fine particles settle to the bottom of the vial leaving a cloudy liquid above them. This is normal. Shake the vial to mix the vaccine with the liquid before using it.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, Chicago, USA; 13th Global Vaccines & Vaccination Summit and Expo, November 08-09, 2016 Istanbul, Turkey; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA; Annual Pennsylvania Immunization Conference, June 16, 2016, PA, USA

Track 15: Passive Immunity:

Passive immunity refers to the process of providing IgG antibodies to protect against infection; it gives immediate, but short-lived protection—several weeks to 3 or 4 months at most. Passive immunity is usually classified as natural or acquired. The transfer of maternal tetanus antibody (mainly IgG) across the placenta provides natural passive immunity for the newborn baby for several weeks/months until such antibody is degraded and lost. In contrast, acquired passive immunity refers to the process of obtaining serum from immune individuals, pooling this, concentrating the immunoglobulins fraction and then injecting it to protect a susceptible person.

Passive immunization is often used in children and adults who have weakened immune systems or may not be good candidates for routine vaccinations for other reasons. It can be used with people who haven’t been vaccinated against a disease to which they’ve been exposed.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; National Adult & Influenza Immunization Summit NAIIS, May 10–12, 2016; 10th ISV Annual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; World Vaccines Congress, 10-12 April, Washington D.C., USA; 6th Immunotherapeutics Immunomonitoring Conference California, USA; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA

Track 16: Vaccines for Vector-borne Diseases:

Vaccines that target blood-feeding disease vectors, such as mosquitoes and ticks, have the potential to protect against the many diseases caused by vector-borne pathogens. Vector-borne diseases are among the most complex of all infectious diseases to prevent and control. Vector- borne diseases, most of which are transmitted in and around the home, are best controlled by a combination of vector control (use of public health insecticides on bednets, or by spraying), medicines and vaccines.

Historically, successful vector-borne disease prevention resulted from management or elimination of vector populations.  Malaria was driven out of the USA and most of Europe in this way. Where vector control has been consistently applied in the past, the results have been dramatic, especially with early efforts to control malaria by spraying the inside surfaces of houses with insecticides. Indoor Residual Spraying (IRS) and long-lasting insecticide treated bednets have been very effective over the last 10 years and are widely regarded as one of the main contributors to the more than 1 million lives saved.

In contrast to expenditure and effort on medicine, diagnostic and vaccine development, relatively little attention was given to vector control in the past.  The foresighted establishment of IVCC in 2005, with a grant from the Bill and Melinda Gates Foundation began the process of bringing Vector Control into the mainstream strategy for future eradication of malaria and other vector-borne diseases.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; International Conference on Cancer Immunology and Immunotherapy, July 28-30, 2016, Australia; 12th Euro Global Summit on Cancer Therapy, Sept 26-28, 2016, UK; International Conference and Exhibition on Pediatric Oncology, Aug 4-6, 2016, Canada; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; 6th Immunotherapeutics Immunomonitoring Conference California, USA; National Adult & Influenza Immunization Summit NAIIS, May 10–12, 2016; 10th ISV Annual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; World Vaccines Congress, 10-12 April, Washington D.C., USA; 6th Immunotherapeutics Immunomonitoring Conference California, USA; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA  

Track 17: DNA Vaccines:

DNA vaccination is a technique for protecting an animal against disease by injecting it with genetically engineered DNA so cells directly produce an antigen, resulting in a protective immunological response.

Vaccination consists of stimulating the immune system with an infectious agent, or components of an infectious agent, modified in such a manner that no harm or disease is caused, but ensuring that when the host is confronted with that infectious agent, the immune system can adequately neutralize it before it causes any ill effect. For over a hundred years vaccination has been effected by one of two approaches: either introducing specific antigens against which the immune system reacts directly; or introducing live attenuated infectious agents that replicate within the host without causing disease synthesize the antigens that subsequently prime the immune system.

The field of DNA vaccination is developing rapidly. Vaccines currently being developed use not only DNA, but also include adjuncts that assist DNA to enter cells, target it towards specific cells, or that may act as adjuvants in stimulating or directing the immune response. Ultimately, the distinction between a sophisticated DNA vaccine and a simple viral vector may not be clear. Many aspects of the immune response generated by DNA vaccines are not understood. However, this has not impeded significant progress towards the use of this type of vaccine in humans, and clinical trials have begun.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, Chicago, USA; 13th Global Vaccines & Vaccination Summit and Expo, November 08-09, 2016 Istanbul, Turkey; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA; Annual Pennsylvania Immunization Conference, June 16, 2016, PA, USA

Track 18: Mucosal vaccines:

Most infectious agents enter the body at mucosal surfaces and therefore mucosal immune responses function as a first line of defence. Protective mucosal immune responses are most effectively induced by mucosal immunization through oral, nasal, rectal or vaginal routes, but the vast majority of vaccines in use today are administered by injection. Immunisation involves the delivery of antigens to the mucosal immune system (dispersed or organised into units such as Peyer’s patches in the intestine or the nasal-associated lymphoid tissue in the oropharangeal cavity). The antigen delivery systems may comprise a simple buffer solution with/without adjuvants or an advanced particulate formulation, such as liposomes or nanoparticles. The most commonly evaluated route for mucosal antigen delivery is oral, but other routes have also been explored.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, Chicago, USA; 13th Global Vaccines & Vaccination Summit and Expo, November 08-09, 2016 Istanbul, Turkey; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA; Annual Pennsylvania Immunization Conference, June 16, 2016, PA, USA

Track 19: Vaccines safety and Efficacy:

Vaccines are the best defense we have against serious, preventable, and sometimes deadly contagious diseases. Vaccines are some of the safest medical products available, but like any other medical product, there may be health risk. Accurate information about the value of vaccines as well as their possible side-effects helps people to make informed decisions about vaccination. The safety of vaccines is carefully monitored, starting early in the product development and continuing for as long as the vaccine is being used. Find out about what is done before and after vaccines are approved for use and what is known about the benefits and safety of specific vaccines. There is a lot of false information about vaccines safety on the Internet. This can be confusing. Discover the answers to common questions and concerns about vaccines.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; National Adult & Influenza Immunization Summit NAIIS, May 10–12, 2016; 10th ISV Annual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; World Vaccines Congress, 10-12 April, Washington D.C., USA; 6th Immunotherapeutics Immunomonitoring Conference California, USA; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA

Track 20: Travel Immunization:

Anyone planning to travel abroad may need immunizations before departure. Although few immunizations are compulsory for international travel, some are recommended for the traveller’s protection. Some vaccines must be given in 2–3 doses several weeks apart. Therefore, a doctor should be consulted at least 2–3 months before departure. Children under 1 year, and people with a compromised immune system or serious underlying disorder may not be able to have some vaccinations, such as those for yellow fever and tuberculosis (BCG). Recommended vaccines are travel vaccinations that can protect you in areas where there is an intermediate or high risk for contracting certain illnesses. They also help prevent the spread of diseases from one country to another.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; National Adult & Influenza Immunization Summit NAIIS, May 10–12, 2016; 10th ISV Annual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; World Vaccines Congress, 10-12 April, Washington D.C., USA; 6th Immunotherapeutics Immunomonitoring Conference California, USA; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA

Track 21: Veterinary vaccines:

Veterinary vaccines are to improve the health and welfare of companion animals, increase production of livestock in a cost-effective manner, and prevent animal-to-human transmission from both domestic animals and wildlife. Several vaccine types can de distinguished among the second-generation veterinary vaccines, depending whether they are live or inactivated, according to the strain of rabies virus used and the characteristics of the cell substrate chosen for viral replication. More recently a third generation of live veterinary rabies vaccine has been developed using recombinant technology. Depending upon the expression system these vaccines are used either parenterally or orally. Oral rabies vaccines are widely used in foxes in Europe and in racoons in the USA.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; 3rd International Veterinary Congress, Aug 18-20, 2016, UK; Veterinary Microbiology Conference, Sept 15-17, 2016, USA; 4th Global Veterinary Summit, November 14-16, 2016, USA; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Rome, Italy; Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, Chicago, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Melbourne, Australia; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA; Annual Pennsylvania Immunization Conference, June 16, 2016, PA, USA

Track 22: Vaccine Adjuvants:

A Vaccine adjuvants is an ingredient of a vaccine that helps create a stronger immune response in the patient’s body.  In other words, adjuvants help vaccines work better. Some vaccines made from weakened or dead germs contain naturally occurring adjuvants and help the body produce a strong protective immune response. However, most vaccines developed today include just small components of germs, such as their proteins, rather than the entire virus or bacteria. These vaccines often must be made with adjuvants to ensure the body produces an immune response strong enough to protect the patient from the germ he or she is being vaccinated against. Aluminum gels or aluminum salts are vaccines ingredients that have been used in vaccines since the 1930s.  Small amounts of aluminum are added to help the body build stronger immunity against the germ in the vaccine. Aluminum is one of the most common metals found in nature and is present in air, food, and water. The amount of aluminum present in vaccines is low and is regulated by the U.S. Food and Drug Administration (FDA).

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; National Adult & Influenza Immunization Summit NAIIS, May 10–12, 2016; 10th ISV Annual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; World Vaccines Congress, 10-12 April, Washington D.C., USA; 6th Immunotherapeutics Immunomonitoring Conference California, USA; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA

Track 23: Tuberculosis Vaccines:

BCG, or bacille Calmette-Guerin (Tuberculosis Vaccines), is a vaccine for tuberculosis (TB) disease. Many foreign-born persons have been BCG-vaccinated. BCG is used in many countries with a high prevalence of TB to prevent childhood tuberculous meningitis and miliary disease. However, Tuberculosis Vaccine is not generally recommended for use in the United States because of the low risk of infection with Mycobacterium tuberculosis, the variable effectiveness of the vaccine against adult pulmonary TB, and the vaccine’s potential interference with tuberculin skin test reactivity. The Tuberculosis Vaccine should be considered only for very select persons who meet specific criteria and in consultation with a TB expert.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; The 2016 TB Summit: 21– 23 June 2016, London, UK; EMBO conference Tuberculosis 2016, September 19-23, 2016, Paris, France; 20th Annual TB Conference, February 24-27, 2016, Colorado, USA; ICTT 2016 : 18th International Conference on Tuberculosis Therapy, February 25 - 26, 2016, London, United Kingdom; 47th Union World Conference on Lung Health, 25-29 October 2016, Liverpool, UK; Joint 20th Conference of The Union North America Region and the National TB Controllers Association, 24-27 February 2016, Colorado, USA;

Track 24: Vaccination for Pregnant Women:

Vaccines can help keep you and your growing family healthy. If you are pregnant or planning a pregnancy, the specific vaccinations you need are determined by factors such as your age, lifestyle, medical conditions you may have, such as asthma or diabetes, type and locations of travel, and previous vaccinations. Benefits of vaccinating pregnant women usually outweigh potential risks when the likelihood of disease exposure is high, when infection would pose a risk to the mother or fetus, and when the vaccine is unlikely to cause harm. All women who will be pregnant (any trimester) during the flu season should be offered this vaccine. Talk to your doctor to see if this applies to you. Tetanus/Diphtheria/Pertussis (Tdap): Tdap is recommended during pregnancy, preferably between 27 and 36 weeks' gestation, to protect baby from whooping cough.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Pregnancy Summit & Child Health, Aug 29-31, 2016, Brazil; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; National Adult & Influenza Immunization Summit NAIIS, May 10–12, 2016; 10th ISV Annual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; World Vaccines Congress, 10-12 April, Washington D.C., USA; 6th Immunotherapeutics Immunomonitoring Conference California, USA; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA

Track 25: Immunization for Older Adults:

Vaccines are an important part of routine preventive care for older adults, but most adults don’t get their vaccines as recommended. Omitting vaccination leaves adults needlessly vulnerable to severe illnesses, long-term suffering and death from preventable infections. Vaccines are recommended for adults of all ages, they are particularly important for older persons who are at great risk of serious debilitating consequences and death from infectious diseases. Vaccination is particularly important for individuals living in nursing homes or assisted living facilities, as disease can spread easily among people in close proximity.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Geriatric Medicine Conference, Nov 17-19, 2016, USA; 3rd International Conference on Geriatrics & Gerontology, Aug 15-17, 2016, UK; 13th Global Vaccines & Vaccination Summit and Expo, November 08-09, 2016 Istanbul, Turkey; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; National Adult & Influenza Immunization Summit NAIIS, May 10–12, 2016; 10th ISV Annual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; World Vaccines Congress, 10-12 April, Washington D.C., USA; 6th Immunotherapeutics Immunomonitoring Conference California, USA; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA

Track 26: Fish Vaccines:

Like all livestock, farmed fish can be protected from disease risks by vaccination. Vaccines have been a major factor in decreasing the use of antibiotics in aquaculture while keeping fish healthy. However, a vaccine is only effective if it is delivered properly into the fish, in the correct place and at the correct dose. Today, therefore, most salmon and many other farmed fish are vaccinated by specialist vaccination companies.

At Aqualife, we are dedicated to ensuring that vaccination is carried out to the highest possible standards. We lead the fish vaccination field and have set new benchmarks for the industry, ensuring every fish is injected accurately, safely and with minimal stress.

Aqualife’s vaccination services are available for the protection of all types of farmed fish, including Cleaner Fish. Our techniques, developed in conjunction with leading experts in the field, are based on vast practical experience and R&D underpinned by good science.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; 2nd Global Summit on Aquaculture & Fisheries, July 11-13, 2016 Kuala Lumpur, Malaysia; 4th International Conference on Aquaculture & Fisheries, Sept 29-Oct 1, 2016, London, UK; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; National Adult & Influenza Immunization Summit NAIIS, May 10–12, 2016; 10th ISV Annual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; World Vaccines Congress, 10-12 April, Washington D.C., USA; 6th Immunotherapeutics Immunomonitoring Conference California, USA; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA

Track 27: Human Preventive and Therapeutic Vaccines:

A preventative vaccine is administered to a person who is free of the targeted infection. By introducing a part of the virus or an inactive virus (which acts like a decoy) into the body, the immune system reacts by producing antibodies. Preventive vaccines are widely used to prevent diseases like polio, chicken pox, measles, mumps, rubella, influenza (flu), and hepatitis A and B.

In addition to preventive vaccines, there are also “therapeutic vaccines”. These are vaccines that are designed to treat people who already have a disease. Some scientists prefer to refer to therapeutic vaccines as “therapeutic immunogens.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; National Adult & Influenza Immunization Summit NAIIS, May 10–12, 2016; 10th ISV Annual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; World Vaccines Congress, 10-12 April, Washington D.C., USA; 6th Immunotherapeutics Immunomonitoring Conference California, USA; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA

Track 28: Plant-based vaccines:

Plant-based vaccines are recombinant protein subunit vaccines. Ideally, the choice of plant species used to produce the selected antigen should allow for oral drug delivery in the form of an edible vaccine. To date, the most advanced human vaccine projects have successfully completed phase I clinical trials, and animal vaccine projects have given promising data in early phase trials targeting specific animal species.

The plant-based vaccine production method works by isolating a specific antigen protein, one that triggers a human immune response from the targeted virus. A gene from the protein is transferred to bacteria, which are then used to “infect” plant cells. The plants then start producing the exact protein that will be used for vaccinations. The flexibility of the plant expressed vaccine system, combined with its low cost and ability to massively scale may provide vaccine protection not only to citizens of the United States, but to many parts of the world that cannot currently afford vaccines. Other uses of plant expressed vaccines including the successful creation of edible bananas that protect against the Norwalk virus.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy; Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, Chicago, USA; 13th Global Vaccines & Vaccination Summit and Expo, November 08-09, 2016 Istanbul, Turkey; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; 10th Vaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDA Vaccines & Related Biological Products Advisory Committee Meeting (VRBPAC) May 11, 2016, MD, USA; Wyoming Immunization Conference, May 11–12, 2016, WY, USA; 14th Annual Vaccines & Therapeutics, May 17–19, 2016, Washington D.C., USA; 2016 National Conference on Immunization Coalitions & Partnerships, May 25–27, 2016, USA; Annual Pennsylvania Immunization Conference, June 16, 2016, PA, USA

ConferenceSeries LLC invites all the participants across the globe to attend 10th Euro Global Summit and Expo on Vaccines & Vaccinationgoing to be held during June 16-18, 2016 in Rome, Italy. The conference highlights the theme “Transforming Health through Vaccine Innovations” covering all important aspects in Vaccination. The conference includes explicit keynote talks from distinguished scientists, plenary sessions, Poster competition, Young Researcher sessions, Symposiums, Workshop and Exhibitions.

Euro Vaccines 2016 hosting presentations from Global Leaders in the field across the Globe and bringing together vaccine stakeholders including academic researchers, public health clinicians, vaccine policy makers, corporate and vaccine manufacturers. With the generous response and support received from the participants of previous annual vaccines conferences.

Why to attend???

With members from around the world focused on learning about Vaccinology/Immunology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Immunology/Vaccinology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new vaccines developments, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Immunology/Vaccinology are hallmarks of this conference.

Target Audience:

  • Vaccinology/Immunology Students, Scientists
  • Vaccinology/Immunology Researchers
  • Vaccinology/Immunology Faculty
  • Medical Colleges
  • Vaccinology/Immunology Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies
  • Machinery Manufacturing Companies

Why to attend???

With members from around the world focused on learning about Vaccinology/Immunology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Immunology/Vaccinology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new vaccines developments, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Immunology/Vaccinology are hallmarks of this conference.

Target Audience:

  • Vaccinology/Immunology Students, Scientists
  • Vaccinology/Immunology Researchers
  • Vaccinology/Immunology Faculty
  • Medical Colleges
  • Vaccinology/Immunology Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies
  • Machinery Manufacturing Companies

- See more at: http://vaccines.global-summit.com/asia-pacific/#sthash.kEnDKYxg.dpuf

 

Euro Vaccines-2016 welcomes attendees, presenters, and exhibitors from all over the world to Rome, Italy. We are delighted to invite you all to attend and register for the “10th Euro Global Summit and Expo on Vaccines & Vaccination” (Euro Vaccines-2016)” which is going to be held during June 16-18, 2016 at Rome, Italy hosted by ConferenceSeries LLC through the theme " Transforming Health through Vaccine Innovations", conference will explore the advances in Vaccines and vaccination. This conference could be an exceptional event that brings along a novel and International mixture of giant and medium cognizance on vaccines and vaccination, leading universities engendering the conference an ideal platform to apportion expertise, foster collaborations across trade and world, and assess elevating technologies across the world.

Vaccination is a key to eradicate the diseases. It is a subject for the professionals who looks beyond the clinical prospects. Euro Vaccines-2016 amasses all the extroverts under one roof of current advances.

For more details please visit- http://vaccines.global-summit.com/europe/

      Vaccinology is a major field in eradication of diseases. Traditional approaches to vaccine design were to emasculate or inactivate the human pathogen or a cognate animal homologue, Vaccinology is the science of vaccine development and how the immune system responds to vaccines, but additionally includes perpetual evaluation of immunization programs and vaccine safety and efficacy, as well as surveillance of the epidemiology of vaccine-preventable diseases. This chapter provides a brief overview of some of the main concepts of immunology and Vaccinology as they relate to immunization.

Why Rome? 

In 2014 there are 10 vaccines and related conferences are held in Rome. Rome City Council provides a free immunisation service for children to help protect them against childhood diseases such as measles, whooping cough, polio and tetanus. Providing a free immunisation service is another way Council delivers towards the Vision. Around 20 Biological giants are working in Rome. Around 10 top universities are working on vaccines research.

Global vaccine market revenues in 2005, 2009 and 2015 (in billion U.S. dollars)

Why to attend???

Euro Vaccines-2016 could be an event that brings along a novel and International mixture of giant and medium Vaccinology innovation and incipient trends in vaccines and vaccination, leading universities and Vaccinology, vaccination research analysis establishments creating the conference an ideal platform to share expertise, foster collaborations across trade and world, and assess rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Vaccinology research are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://vaccines.global-summit.com/europe/sponsors.php

Major Vaccines Associations in & around Rome:

  • Sclavo Vaccine Association
  • Vaccines Europe
  • The European Malaria Vaccine Development Association
  • GAVI, The Vaccine Alliance
  • European Society for Paediatric Infectious Diseases 
  • European Federation of Immunological Societies 

Major Vaccines Associations Globally

  • The International Society for Interferon and Cytokine Research
  • The International Society of Neuroimmunology
  • The International Union of Immunological Societies
  • The Society for Mucosal Immunology
  • The Society for Leukocyte Biology
  • Transplantation Society
  • British Society for Immunology
  • Cell Death Society
  • European Society of Gene Therapy
  • Federation of African Immunological Societies
  • Federation of American Societies for Experimental Biology
  • Federation of Clinical Immunology Societies
  • Immune Deficiency Foundation
  • Infectious Diseases Society of America

Target Audience:

Euro Vaccines-2016 Targets, CEO’s, Directors, Scientists, Professors, Students of all Biotech & Pharma companies, Universities and colleges globally.

Top 10 pharmaceutical companies based on global vaccine revenue market share in 2014 and 2020:

This statistic displays the top 10 global pharmaceutical companies based on their vaccine revenue market share worldwide in 2014, and a projection for 2020. Pfizer is expected to account for nearly 21 percent of the global vaccine market share by 2020, largely due to success with its pneumococcal vaccine, Prevnar 13. A vaccine often contains an agent that is made from a weakened form of a disease microbe, that is then used to stimulate the body's immune system to destroy and recognize the microorganism in case of later exposures.

In and Nearby Universities:

  • Sapienza University of Rome
  • Università Campus Bio-Medico di Roma
  • Catholic University of Rome
  • Tor Vergata University in Rome
  • Pavia University in Italy
  • University of Padova

Top Global Immunology Universities:

Rank           University Name

1                 Harvard University

2                University of California--San Francisco

3                Stanford University

3               Yale University

5               Johns Hopkins University

5               Washington University in St. Louis

7               Duke University

7               University of Pennsylvania

9              University of Texas Southwestern Medical Center--Dallas

Companies Associated with Vaccines

  • CareDx
  • Atara
  • Biotherapeutics
  • Benitec Limited  
  • InterMune
  • Biotron Limited
  • BioDiem
  • Antisense Therapeutics Limited           
  • GlaxoSmithKline Australia Pty Ltd
  • Bionomics
  • Australian Pharmaceutical Industries (API)   
  • BioPharmica Limited

Market Analysis of Vaccines

This statistic displays the top 5 global vaccine products based on their revenues worldwide in 2014, and a projection for 2020. Pfizer's pneumococcal vaccine, Prevnar 13, is expected to generate 5.8 billion U.S. dollars in revenues by 2020. A vaccine often contains an agent that is made from a weakened form of a disease microbe, that is then used to stimulate the body's immune system to destroy and recognize the microorganism in case of later exposures.

Top 5 global vaccine products based on revenue in 2014 and 2020 (in million U.S. dollars)

 

See more at: http://vaccines.global-summit.com/europe/

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date June 16-18, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2 Day 3
Poster Opportunity Closed Click Here to View

Media Partners